Banner - NPPA Connect

Opinion|Videos|October 18, 2024

Defining Treatment Success with Oral Treatments in Patients with Plaque Psoriasis

Author(s)E. James Song, MD, FAAD

E. James Song, MD, FAAD, provides key takeaways on the treatment of patients with plaque psoriasis, highlighting ways to define treatment success and the effect of adverse events on long-term treatment choices.

Episodes in this series

E. James Song is featured in this video series.

EP. 1 Evolution of Plaque Psoriasis Understanding, Pathophysiology, and Treatment Options

E. James Song is featured in this video series.

EP. 2 Morphological Differences of Plaque Psoriasis vs Eczema Skin Conditions

E. James Song is featured in this video series.

EP. 3 Role of PDE-4 in the Management of Plaque Psoriasis

E. James Song is featured in this video series.

EP. 4 Management of Plaque Psoriasis in a 45-year-old Woman via Telemedicine

E. James Song is featured in this video series.

EP. 5 Optimizing Therapy Escalation: Navigating Insurance Barriers and Step Therapy for Patients with Plaque Psoriasis

E. James Song is featured in this video series.

EP. 6 Case 1: Evaluating Treatment History and Future Management Strategies for a Patient with Mild-to-Moderate Plaque Psoriasis

E. James Song is featured in this video series.

EP. 7 Comparison of Systemic Therapies for Plaque Psoriasis

E. James Song is featured in this video series.

EP. 8 Case 2: Management of a 58-Year-Old Patient with Location-Specific Plaque Psoriasis, Psoriatic Arthritis, Type 2 Diabetes, and Obesity

E. James Song is featured in this video series.

EP. 9 Defining Treatment Success with Oral Treatments in Patients with Plaque Psoriasis

E. James Song is featured in this video series.

EP. 10 Treatment Considerations for Patients with Skin and Joint Involvement in Plaque Psoriasis

EP. 11 Tailored Strategies and Evolving Therapies for Plaque Psoriasis

EP. 11 Tailored Strategies and Evolving Therapies for Plaque Psoriasis

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

GPP Awareness Day: Flare Triggers and IL-36 Targeted Therapy With Spesolimab

ByAaron S. Farberg, MD,Kaitlyn Bader, Assistant Managing Editor

August 13th 2026

GPP Awareness Day: Recognizing Severity Across Care Settings

ByAaron S. Farberg, MD,Kaitlyn Bader, Assistant Managing Editor

August 13th 2026

Addressing Treatment Hesitancy in Pediatric Psoriasis

ByEileen Cheever, MPAS, PA-C,Shannon Heaning, Content Associate

August 13th 2026

GPP Awareness Day: Highlighting the Need for Faster Diagnosis

ByAaron S. Farberg, MD,Kaitlyn Bader, Assistant Managing Editor

August 13th 2026

Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension

ByShannon Heaning, Content Associate

August 11th 2026

Latest CME

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Adaptive Learning

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Corey Cutler, MD, MPH, FRCP(C); Amin M. Alousi, MD; Mehdi Hamadani, MD; Anna Sureda, MD, PhD

Trending on Dermatology Times

Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension

Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease

Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine

Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial

Probiotics in Hidradenitis Suppurativa: Biologic Rationale vs. Clinical Evidence